PIK3CA and neoplasm: Furthermore, cotreatment of UPS xenografts in immunodeficient mice with a dual PI3K/mTOR inhibitor and an anti-IGF1R kinase inhibitor reduced tumor growth in vivo, while also decreasing UPS cell migration and invasion in vitro [116].